TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.

Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...

在其他近期新闻中，TransMedics Group完成了一批飞机的收购，以增强其器官运输能力，使飞机总数达到20架。公司第三季度收入同比增长64%，达到1.088亿美元，主要由美国销售额76%的增长推动。TransMedics修订了2024财年的收入指引，预计在4.28亿美元至4.32亿美元之间。分析师反应不一，Piper ...

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

TMDX was the top contributor in Q2 (and I trimmed the position at that time given stretched valuation). Fast forward to Q4 and the narrative around this company has completely changed.

TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.

TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...

TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...

JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...

January 18, 2025, 05:16 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...